|
To,
The Members,
Your Directors have pleasure in presenting their 08th Annual Report of
Astonea Labs Limited (formerly known as Astonea Labs Private Limited) on the business
and operations of the Company and the accounts for the Financial Year ended March 31,
2025.
1. FINANCIAL SUMMARY OR HIGHLIGHTS/PERFORMANCE OF THE COMPANY
| PARTICULARS |
For the Financial Year Ended 2024-25 |
(Amount in Lakhs) For the Financial Year Ended 2023-24 |
| Revenue from Operations |
9751.83 |
8019.09 |
| Other Income |
18.93 |
9.76 |
| Total Income |
9770.77 |
8028.86 |
| Total Income before Finance Cost, Depreciation |
1530.85 |
662.85 |
| Finance Cost |
365.61 |
295.98 |
| Depreciation |
458.13 |
366.87 |
| Profit Before Tax(PBT) |
707.11 |
537.85 |
| Current Tax |
198.84 |
162.77 |
| Deferred Tax |
(26.79) |
31.93 |
| Profit After Tax (PAT) |
535.05 |
407.01 |
2. STATE OF COMPANY'S AFFAIR
During the financial year 2024-25, the Company registered a significant improvement in
financial performance, recording a Profit Before Tax (PBT) of Rs. 707.11 lakhs, as against
Rs. 537.85 lakhs in FY 2023-24, representing a growth of 31.47%. Profit After Tax (PAT)
rose to Rs. 535.05 lakhs, compared to Rs. 407.01 lakhs in the previous year, achieving a
31.46% increase. This upward trajectory underscores the Company's strategic efforts in
strengthening operational efficiencies, optimizing cost structures, and maintaining
consistent revenue growth.
3. CHANGE IN THE NATURE OF BUSINESS, IF ANY/MATERIAL CHANGES AFFECTING FINANCIAL
POSITION OF THE COMPANY
The Board notes that the period subsequent to the financial year-end has not witnessed
any material developments or commitments that would impact the Company's financial
position or modify the nature of its business. The Company remains firmly positioned in
the manufacturing domain of pharmaceuticals and cosmetic products.
4. DIVIDEND
The Board notes that the period subsequent to the financial year-end has not witnessed
any material developments or commitments that would impact the Company's financial
position or modify the nature of its business. The Company remains firmly positioned in
the manufacturing domain of pharmaceuticals and cosmetic products.
5. TRANSFER OF UNCLAIMED DIVIDEND TO INVESTOR EDUCATION AND PROTECTION FUND
(IEPF):
The Company has not declared or distributed any dividend during the financial year.
Accordingly, the provisions of Section 125(2) of the Companies Act, 2013, pertaining to
the transfer of unclaimed dividend to the Investor Education and Protection Fund (IEPF),
are not applicable for the year under review.
6. TRANSFER TO RESERVE
The Board of Directors of your company has not decided to transfer any amount to the
General Reserves for the financial year under review.
7. material/ significant events subsequent to the reporting period
The Directors have reviewed all events occurring after the close of the financial year
on 31st March 2025 and up to the date of signing of this Board Report. The Board has
examined whether any such events have a material impact on the Company's financial
position, operations, or future outlook and, accordingly, whether they require disclosure
or adjustments in the financial statements as per applicable accounting standards and
regulatory requirements.
6. TRANSFER TO RESERVE
The Board of Directors of your company has not decided to transfer any amount to the
General Reserves for the financial year under review.
Listing on Stock Exchange
Subsequent to the conclusion of the financial year, the Company attained a major
corporate milestone by achieving a listing on the BSE SME Platform in June 2025, thereby
formalizing its transition into a publicly traded entity. This listing represents a
significant step in the Company's growth trajectory, enhancing its visibility,
credibility, and investor confidence in the capital markets. Furthermore, it provides the
Company with a robust platform to mobilize financial resources to support its strategic
growth initiatives, expansion plans, and long-term business objectives.The process of
listing followed a structured regulatory and procedural timeline:
Draft Red Herring Prospectus (DRHP) filed with SEBI in August 2024
Red Herring Prospectus (RHP) and Prospectus filed in May 2025
Successful listing on the BSE SME Platform in June 2025
As a direct consequence of the Initial Public Offering (IPO), the paid-up share capital
of the Company increased from Rs. 7.60 crore to Rs. 10.51 crore, reflecting the issuance
of additional equity shares to the public. This capital infusion not only strengthens the
financial position of the Company but also enhances its capacity to fund future growth,
operational expansion, and strategic initiatives.
Change in Directorship and Key Managerial Personnel (kmp)
| Name |
Designation |
Details of Appointment |
| 1. Mr. Arun Kumar Tripathi |
Additional Director (Non-Executive, Non-Independent Director) |
Appointed with effect from 10th November 25, as approved in the Board
Meeting held on the same date. |
| 2. Mr. Pardeep Dalal |
Additional Director (Non-Executive, Non-Independent Director) |
Appointed w.e.f. 10th Nov, 2025 Board Meeting |
| 3. Mr. Vikrant |
Additional Director (Non-Executive, Non-Independent Director) |
Appointed w.e.f. 10th Nov, 2025 Board Meeting |
Change in Key Managerial Personnel (kmp)
During the period following the financial year, the Company witnessed certain changes
in its Key Managerial Personnel, as detailed below:
| Name |
Designation |
Details of Appointment |
| 1. Mrs. Avneet Kaur |
Company Secretary & Compliance Officer |
Resigned on 5th June 2025; last working day was 4th July 2025. |
| 2. Mr. Vijay Kumar |
Company Secretary & Compliance Officer |
Appointed on 1st September 2025; resigned on 20th September 2025. |
It is pertinent to note that the appointment of Mr. Ankit Kapoor as Company Secretary
and Compliance Officer, with effect from 3rd December 2025, is currently placed before the
Board for its approval.
The Board places on record its appreciation for the valuable contributions of outgoing
KMPs and welcomes the newly appointed personnel, confident that their expertise will
support the Company's governance, regulatory compliance, and strategic objectives.
8. CHANGE IN CORPORATE STATUS/ NAME
The Company has not undergone any change in its name during the financial year 2024-25.
However, it is pertinent to note that the Company was converted from a Private Limited
Company to a Public Limited Company on 11th January 2024, consequent to which the name
changed from Astonea Labs Private Limited to Astonea Labs Limited.
Subsequent to the conclusion of the financial year, the Company achieved a significant
milestone by attaining a listing on the BSE SME Platform in June 2025, thereby formalizing
its status as a publicly traded entity. This listing enhances the Company's visibility and
credibility in the capital markets and provides an important avenue to mobilize resources
to support its strategic growth and long-term business objectives.
9. SHARE CAPITAL
The Company's Authorised Share Capital stands at Rs. 11,50,00,000/-, divided into
1,15,00,000 equity shares of Rs. 10/- each. During the financial year 2024-25, the Paid-up
Share Capital was Rs. 7,60,00,000/-, comprising 76,00,000 equity shares of Rs. 10/- each.
Subsequent to the close of the financial year, the Company successfully completed an
Initial Public Offering (IPO), mobilizing additional capital from public investors. As a
result, the Paid-up Share Capital increased to Rs. 10,51,10,000/-, representing
1,05,11,000 equity shares of Rs. 10/- each, marking a significant milestone in the
Company's evolution as a publicly listed entity. This capital infusion strengthens the
Company's financial position and enhances its ability to fund strategic growth initiatives
and long-term business objectives.
1.WEB LINK OF ANNUAL RETURN
Pursuant to Section 134(3)(a) read with Section 92(3) of the Companies Act, 2013, the
Annual Return of the Company for the financial year 2024-25 has been duly placed at
www.astonea.org.
11. DETAILS OF DIRECTORS, KEY MANAGERIAL PERSONNEL (KMP) AND SENIOR MANAGEMENT
PERSONNEL (SMP)
During the financial year, there are following changes in directorship : Appointment:
| NAME OF THE DIRECTOR |
DESIGNATION |
DATE |
REMARKS |
| KHYATIAVNISH |
Independent Director |
14.09.2024 |
Appointed as an Additional Independent Director of the Com an |
| POOJA SINGH |
Executive Director |
17.09.2024 |
Regularised as an Executive Director of the Company. |
| KHYATI AVNISH |
Independent Director |
20.09.2024 |
Re-designated as an Independent Director of the Com an . |
| AKASH ARORA |
Independent Director |
15.01.2025 |
Appointed as an Independent Director of the Company |
Resignation:
| NAME OF THE |
DESIGNATION |
DATE |
REMARKS |
| DIRECTOR KHYATI AVNISH |
Independent Director |
15.01.2025 |
Resigned from the designation of Independent Director of the Company. |
During the financial year, there are following changes in KMP : Appointment:
| NAME |
DESIGNATION |
DATE |
REMARKS |
| SUMIT KUMAR |
Chief Financial Officer (CFO) |
01.04.2024 |
Appointed as the Chief Financial Officer of the Company. |
| AVNEET KAUR |
Company Secretary and Compliance Officer (CS) |
06.05 2024 |
Appointed as Company Secretary and Company Compliance Officer of the
Company. |
Resignation:
There were no resignations by any Key Managerial Personnel during the financial year
2024-25. However, subsequent to the close of the financial year, Mrs. Avneet Kaur, Company
Secretary and Compliance Officer of the Company, tendered her resignation on 5th June
2025.
During the financial year, there are following changes in SMP : Appointment:
| NAME |
DESIGNATION |
DATE |
REMARKS |
| Ashish Saxena (SMP) |
Assistant General Manager - Quality Assurance |
September 29, 2024 |
Resignation as Assistant General Manager - Quality Assurance for better
growth opportunities. |
12. DIRECTOR'S IDENTIFICATION NUMBER (DIN)
The Board confirms that all serving Directors possess valid Director Identification
Numbers (DINs). The Company and its Directors have adhered to the requirements laid down
under the Companies (Appointment and Qualification of Directors) Rules, 2014.
13. UNSECURED LOAN FROM DIRECTORS
During the financial year 2024-25, the Company had unsecured loans totaling Rs. 556.41
lakhs from its Directors and their relatives. This includes loans from Mr. Harsh Gulati
and Mrs. Usha Gulati, who are relatives of a Director and held directorships until 9th
October 2023, amounting to Rs. 551.85 lakhs, and from Mr. Ashish Gulati, amounting to Rs.
4.56 lakhs. All such loans were extended on mutually agreed terms and in full compliance
with the provisions of the Companies Act, 2013.
14. PARTICULARS OF EMPLOYEES
The Company did not have any employee drawing remuneration in excess of limits
specified under section 197(12) of the Companies Act, 2013 read with companies
(Appointment and Remuneration of Managerial Personnel) rules, 2014. Therefore, the
information to be furnished under this section is NIL.
15. REGISTRAR AND SHARE TRANSFER AGENTS
During the year under review, KFin Technologies Limited acted as the Registrar and
Share Transfer Agent of the Company, handling the management of share registry, transfers,
and related shareholder services.
16. MEETINGS
The Board of Directors met 29 Times during the Financial Year 2024-25. The maximum gap
between any two Board Meetings was less than one Hundred and Twenty days.
| Date of Meeting |
| 01.04.2024 |
| 03.04.2024 |
| 22.04.2024 |
| 02.05.2024 |
| 29.05.2024 |
| 31.05.2024 |
| 12.06.2024 |
| 19.06.2024 |
| 29.06.2024 |
| 27.07.2024 |
| 02.08.2024 |
| 12.08.2024 |
| 16.08.2024 |
| 14.09.2024 |
| 27.09.2024 |
| 01.10.2024 |
| 10.10.2024 |
| 26.10.2024 |
| 29.11.2024 |
| 03.12.2024 |
| 17.12.2024 |
| 03.01.2025 |
| 15.01.2025 |
| 21.01.2025 |
| 27.01.2025 |
| 28.01.2025 |
| 01.02.2025 |
| 18.03.2025 |
| 26.03.2025 |
17. FRAUD REPORTING UNDER SECTION 143(12) OF THE COMPANIES ACT, 2013
Pursuant to the provisions of the Companies Act, 2013, and in accordance with the
report submitted by the statutory auditors for the financial year 2024-25, it is confirmed
that no instances of fraud, misappropriation, or financial irregularities have been
observed or reported. The Board further affirms that adequate internal controls and
governance mechanisms are in place to safeguard the Company's assets and to prevent any
potential fraudulent activities.
18. DETAILS OF SUBSIDIARY/JOINT VENTURES/ASSOCIATE COMPANIES
During the financial year 2024-25, the Company did not have any subsidiary, joint
venture, or associate entity. As such, there are no disclosures required under this head,
and the provisions relating to consolidation or related reporting are not applicable to
the Company for the year under review.
19. STATUTORY AUDITOR & AUDIT REPORT
At the Annual General Meeting held on 30th September, 2023, M/s AVNISH SHARMA &
ASSOCIATES, Chartered Accountants, Panchkula having FRN: 009398N was appointed as
Statutory Auditor for a five periods to hold office till the conclusion of the Annual
General Meeting of the Company for the financial year 2027-18.
Further the Statutory Auditors of the Company have submitted Auditor's Report for the
financial year ended 31.03.2025. The Statutory Auditors' Report for the financial year
under review does not contain any qualification, reservation, adverse remark, or
disclaimer. The observations made by the Auditors in their Report and the Notes to the
Financial Statements are selfexplanatory and do not require any further clarification or
comments
20. COST AUDIT & AUDIT REPORT
During the year under review, KFin Technologies Limited acted as the Registrar and
Share Transfer Agent of the Company, handling the management of share registry, transfers,
and related shareholder services. The remuneration payable to the Cost Auditors shall be
ratified by the shareholders at the ensuing Annual General Meeting, as required under
Section 148(3) of the Act.
21.SECRETARIAL AUDIT & AUDIT REPORT
The requirement to conduct a Secretarial Audit under Section 204 of the Companies Act,
2013, was not applicable to the Company in the preceding financial years. Consequent to
the Company's listing on the BSE SME Platform, the provisions relating to Secretarial
Audit have now become applicable for the first time for the financial year 2024-25.
In view of the above, the Board of Directors has appointed M/s S. V. Associates,
Practising Company Secretaries, as the Secretarial Auditors of the Company to carry out
the Secretarial Audit for the financial year 2024-25. The Secretarial Audit Report, issued
in Form MR-3, will be annexed to this Annual Report in compliance with the statutory
requirements.
The Board further affirms that M/s S. V. Associates have confirmed their consent,
eligibility, and independence to undertake the said audit.
22. INTERNAL AUDITOR
In accordance with the provisions of Section 138 of the Companies Act, 2013 and the
Companies (Accounts) Rules, 2014, the Board of Directors of the Company has appointed M/s
Goyal Rohit & Associates, Chartered Accountants, as the Internal Auditors of the
Company for the financial year 2024-25.
The Internal Auditors are entrusted with the responsibility of reviewing and assessing
the adequacy and effectiveness of the Company's internal control systems, financial
reporting mechanisms, and operational processes. Their observations and recommendations
are periodically presented to the Audit Committee and the Board for review, ensuring that
corrective measures are taken, and internal governance is strengthened.
The Board confirms that M/s Goyal Rohit & Associates possess the requisite
expertise, independence, and professional credentials to carry out their duties
effectively for the financial year 2024-25.
23. COMMITTEES OF THE BOARD
In view of the Company's strategic objective to undertake an Initial Public Offering
(IPO), the Board, during the financial year 2024-25, constituted several specialized
Board-level committees in accordance with the provisions of the Companies Act, 2013 and
the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. These
committees were formed to ensure comprehensive corporate governance, strict compliance
with applicable statutory and regulatory requirements, and effective oversight of all
aspects of the IPO process. The establishment of these committees underscores the
Company's commitment to transparency, accountability, and adoption of best practices in
corporate governance in preparation for its transition into a publicly listed entity
|